BioCentury
ARTICLE | Clinical News

LX4211 tablet: Completed Phase IIb enrollment

February 27, 2012 8:00 AM UTC

Lexicon disclosed in its 4Q11 earnings that it completed enrollment of 299 adult diabetics on metformin monotherapy in a double-blind, placebo-controlled, U.S. Phase IIb trial evaluating once-daily 75...